Company intelligence / Profile preview

Hangzhou Leyi Biotechnology

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Commercial

Overview

Hangzhou Leyi Biotechnology (also known as LEYI® or Hangzhou Leyi New Material Technology) is a high-tech company founded in 2015 that focuses on the research and development of new biocompatible materials for 3D printing, particularly for dental and medical applications. Their products include high precision photopolymer resins used in dental modeling, implants, and orthodontics. The company’s offerings are CE certified for medical use and are commercially available.[4]

Therapeutic areas: Other
Modalities: Biologic (for dental and medical 3D printing materials)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Hangzhou Leyi Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Leyi Biotechnology.

Explore the full profile